Second-look operation in pancreatic carcinoma previously assessed as unresectable;Pankreasmalignom: Second-Look-Operation trotz auswärtiger Inoperabilität?

Zentralblatt fur Chirurgie - Zeitschrift fur Allgemeine, Viszeral- und Gefasschirurgie

Volumn 135, Issue 1, 2010, Pages 70-74

  Warnick, P ^a   Bahra, M ^a   Andreou, A ^a   Neuhaus, P ^a   Glanemann, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Pancreatic carcinoma; Pancreatic surgery; Reoperation; Resectability; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT TUMOR; CANCER INVASION; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FEMALE; FOLLOW UP; GENERAL HOSPITAL; GERMANY; HUMAN; MALE; MIDDLE AGED; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PANCREAS; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PATIENT REFERRAL; PROGNOSIS; REOPERATION; STATISTICS; SURVIVAL RATE; UNIVERSITY HOSPITAL; VATER PAPILLA;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; AMPULLA OF VATER; CARCINOMA, PANCREATIC DUCTAL; COMMON BILE DUCT NEOPLASMS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GERMANY; HOSPITALS, GENERAL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PALLIATIVE CARE; PANCREAS; PANCREATIC NEOPLASMS; PROGNOSIS; REFERRAL AND CONSULTATION; REOPERATION; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77149179059     PISSN: 0044409X     EISSN: 14389592     Source Type: Journal    
DOI: 10.1055/s-0029-1224749     Document Type: Article

References (28)

1. Al-Haddad M, Martin J K., Nguyen J et al. Vascular resection and reconstruction for pancreatic malignancy: a single center survival study. J Gastrointest Surg 2007 11 1168-1174
2. Birkmeyer J D., Siewers A E., Finlayson E V. et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002 346 1128-1137
3. Birkmeyer J D., Skinner J S., Wennberg D E. Will volume-based referral strategies reduce costs or just save lives? Health Aff (Millwood) 2002 21 234-241
4. Birkmeyer J D., Stukel T A., Siewers A E. et al. Surgeon volume and operative mortality in the United States. N Engl J Med 2003 349 2117-2127
5. Birkmeyer J D., Sun Y, Goldfaden A et al. Volume and process of care in high-risk cancer surgery. Cancer 2006 106 2476-2481
6. Birkmeyer J D., Sun Y, Wong S L. et al. Hospital volume and late survival after cancer surgery. Ann Surg 2007 245 777-783
7. Chao C, Hoffman J P., Ross E A. et al. Pancreatic carcinoma deemed unresectable at exploration may be resected for cure: an institutional experience. Am Surg 2000 66 378-385 discussion 386
8. Compton C C., Henson D E. Protocol for the examination of specimens removed from patients with carcinoma of the exocrine pancreas: a basis for checklists. Cancer Committee, College of American Pathologists. Arch Pathol Lab Med 1997 121 1129-1136
9. DGAV. Zertifizierung Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie e.V. (DGAV). http://www.dgav.de/zertifizierung/ (accessed 29.6.2009) 2009
10. DGVS. S3-Leitlinie Exokrines Pankreaskarzinom. http://www.dgvs.de/1035. php (accessed 30.8.2009) 2007
11. Garcea G, Dennison A R., Pattenden C J. et al. Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature. Jop 2008 9 99-132
12. Jaeck D, Bachellier P, Oussoultzoglou E et al. [Analysis of a series of 100mesenterico-portal vein resections during pancreatic resection]. Bull Acad Natl Med 2006 190 1495-1506 discussion 15061499
13. Kotwall C A., Maxwell J G., Brinker C C. et al. National estimates of mortality rates for radical pancreaticoduodenectomy in 25000patients. Ann Surg Oncol 2002 9 847-854
14. Luttges J, Zamboni G, Kloppel G. Recommendation for the examination of pancreaticoduodenectomy specimens removed from patients with carcinoma of the exocrine pancreas. A proposal for a standardized pathological staging of pancreaticoduodenectomy specimens including a checklist. Dig Surg 1999 16 291-296
15. McGuire G E., Pitt H A., Lillemoe K D. et al. Reoperative surgery for periampullary adenocarcinoma. Arch Surg 1991 126 1205-1210 discussion 12101212
16. Michalski C W., Kleeff J, Bachmann J et al. Second-look operation for unresectable pancreatic ductal adenocarcinoma at a high-volume center. Ann Surg Oncol 2008 15 186-192
17. Neoptolemos J P., Dunn J A., Stocken D D. et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 2001 358 1576-1585
18. Oettle H, Neuhaus P. Adjuvant therapy in pancreatic cancer: a critical appraisal. Drugs 2007 67 2293-2310
19. Riediger H, Makowiec F, Fischer E et al. Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection. J Gastrointest Surg 2006 10 1106-1115
20. Robinson E K., Lee J E., Lowy A M. et al. Reoperative pancreaticoduodenectomy for periampullary carcinoma. Am J Surg 1996 172 432-437 discussion 437438
21. Schnelldorfer T, Ware A L., Sarr M G. et al. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg 2008 247 456-462
22. Seelig M H., Chromik A M., Weyhe D et al. Pancreatic redo procedures: to do or not to do this is the question. J Gastrointest Surg 2007 11 1175-1182
23. Settmacher U, Langrehr J M., Husmann I et al. Viszeralarterienrekonstruktionen mit Homografts bei Resektionen des Pankreas. Chirurg 2004 75 1199-1206
24. Shukla P J., Qureshi S S., Shrikhande S V. et al. Reoperative pancreaticoduodenectomy for periampullary carcinoma. ANZ J Surg 2005 75 520-523
25. Siriwardana H P., Siriwardena A K. Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer. Br J Surg 2006 93 662-673
26. Sohn T A., Lillemoe K D., Cameron J L. et al. Reexploration for periampullary carcinoma: resectability, perioperative results, pathology, and long-term outcome. Ann Surg 1999 229 393-400
27. Tyler D S., Evans D B. Reoperative pancreaticoduodenectomy. Ann Surg 1994 219 211-221
28. Willett C G., Czito B G., Bendell J C. Adjuvant therapy of pancreatic cancer. Cancer J 2007 13 185-191